Kymera Therapeutics News

Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Esposito Pamela

Dec 2 19:56 ET

Kymera Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 2 16:46 ET

Kymera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Atlas Venture Fund X, L.P.(6.4%),Atlas Venture Associates X, L.P.(6.4%), etc.

Nov 14 16:36 ET

Kymera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(10.3%)

Nov 14 13:40 ET

Kymera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(9.99%),Behzad Aghazadeh(9.99%)

Nov 14 09:36 ET

Kymera Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-FMR LLC(7.933%),Abigail P. Johnson(7.933%)

Nov 12 10:38 ET

Kymera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(7.17%),Wellington Group Holdings LLP(7.17%), etc.

Nov 8 10:55 ET

Kymera Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Oct 31 08:16 ET

Kymera Therapeutics | 10-Q: Q3 2024 Earnings Report

Oct 31 07:50 ET

Kymera Therapeutics | 8-K: Kymera Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business Update

Oct 31 07:41 ET

Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Esposito Pamela

Sep 17 18:25 ET

Kymera Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Sep 17 16:45 ET

Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.

Aug 26 18:36 ET

Kymera Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 26 16:37 ET

Kymera Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 26 16:27 ET

Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BVF PARTNERS L P/IL

Aug 22 17:10 ET

Kymera Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(9.3%),Baker Bros. Advisors (GP) LLC(9.3%), etc.

Aug 22 16:21 ET

Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LP

Aug 22 16:05 ET

Kymera Therapeutics | 8-K: Current report

Aug 20 17:28 ET

Kymera Therapeutics | 424B5: Prospectus

Aug 20 16:34 ET